Clin2
NCT07119580Possibly a fitRecruiting

Glaucoma, eye surface health, and tear proteins

GlaucomaOcular HypertensionLimbal Stem Cell Deficiency

Part of Eyes & vision clinical trials.

This study looks at how glaucoma and its treatments affect the surface of the eye and proteins in tears. It may help find better ways to manage eye health in people with glaucoma.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
90 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You either have no glaucoma, or you have a specific type of glaucoma (angle-closure, open-angle, or high eye pressure) that fits one of the study groups.
  • You have not had severe eye injuries, chemical burns, or certain eye surgeries.
  • You do not have other eye surface problems that are not related to glaucoma or dry eye.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05039684Recruiting
Testing eye-surface inflammation in glaucoma or high eye pressure

This study measures inflammation markers on the eye surface in people with primary open-angle glaucoma or ocular hypertension who use certain glaucoma drops. The results may help doctors understand how these drops affect the eye and inflammation.

Valladolid
NCT06827535Enrolling by invitation
Long-term study of eye changes in glaucoma and high eye pressure

This study tracks changes in blood flow, structure, and vision over time in people with glaucoma or high eye pressure. It aims to understand how these conditions progress, which could help improve future treatment.

Milan, Italy
NCT06452316Recruiting· Phase 1
Eye drop study for limbal stem cell deficiency

This study tests a new eye drop called CSB-001 for people with limbal stem cell deficiency (LSCD), a condition that damages the cornea. The goal is to see if the drops can help improve the health of the cornea and reduce inflammation.

Loma Linda, California
NCT07636590Recruiting
Study of vision changes in limbal stem cell deficiency

This observational study follows patients with limbal stem cell deficiency (a condition affecting cells at the edge of the cornea that help maintain healthy eye surface) to understand how their vision changes over time. Researchers will track your eye health without giving you new treatment.

Carmel, Indiana
NCT07217678Recruiting· Phase 4
Eye drops and surface damage in glaucoma treatment

This study looks at how certain glaucoma eye drops affect the surface of your eye. It tests a new implant that may reduce damage and improve comfort.

Miami, Florida
NCT00286637Recruiting
New tests to diagnose glaucoma and related eye problems

This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.

Philadelphia, Pennsylvania

Hear when a new Glaucoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.